Floatz logo

MANNITOL

Obesity, Morbid

Pichamol Jirapinyo, MD, MPHSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

41 Active assets in the Obesity, Morbid cohort.

Asset / SponsorPhaseRating
Liraglutide
University of Sao Paulo General Hospital
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Tanta University
Phase 4BB
Semaglutide
Zuyderland Medisch Centrum
Phase 4BB
BISMUTH SALICYLATE
Fatih Sultan Mehmet Training and Research Hospital
Phase 4BB
DEXKETOPROFEN
Kirsehir Ahi Evran Universitesi
Phase 4BB

View all 50 →

Same molecule, other indications

MANNITOL is also rated in:

cystic fibrosisDormant
BB
Indicative ·
69 / 100
View asset →
Intracranial HypertensionDormant
BB
Indicative ·
67 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →